Clinical Trial Update: Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results for ABT-510, a thrombospondin-1 mimetic, in patients with advanced head and neck cancer across Phase 1 and Phase 2; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ABT-510 (ABT-510)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2009-06-12